When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
MD Osamah Z. Badwan,MD Lorenzo Braghieri,3 Authors,MD W. H. Wilson Tang
2024 · DOI: 10.3949/ccjm.91a.23034
Cleveland Clinic journal of medicine · 4 Citations
Abstract
Evidence from clinical trials supports starting these medications as early as possible in patients hospitalized with acute decompensated heart failure who do not have clear contraindications to them.
Cited Papers
Citing Papers